Search research articles
Contact Us
Filters
Showing results (1-10 of 6) with videos related to
Page
of 1
Sort By:
Pediatric Dermatology
|
April 5, 2005
Vaccine-associated "wild-type" measles
Kelle Liermann Berggren, Michael Tharp, Kenneth M Boyer
International Journal of Dermatology
|
August 23, 2008
Clinicopathologic challenge. Gangrenous cellulitis caused by Peptostreptococcus
Tracy Campbell, Rachel Altman, Michael Tharp, et al.
American Journal of Clinical Dermatology
|
August 12, 2006
Single-day therapy for recurrent genital herpes
Stephen Tyring, Tim Berger, Angela Yen-Moore, et al.
International Journal of Dermatology
|
March 15, 2006
Prodromal bullous pemphigoid
Philina M Lamb, Edward Abell, Michael Tharp, et al.
Journal of the American Academy of Dermatology
|
February 10, 2024
Efficacy and safety of crisaborole ointment, 2%, in participants aged ≥45 years with stasis dermatitis: Results from a fully decentralized, randomized, proof-of-concept phase 2a study
Jonathan I Silverberg, Robert S Kirsner, David J Margolis, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
May 18, 2011
Multicenter photopheresis intervention trial in early-stage mycosis fungoides
Rakhshandra Talpur, Marie Francis Demierre, Larisa Geskin, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 6) with videos related to
Sort By:
Page
of 1
Pediatric Dermatology
|
April 5, 2005
Vaccine-associated "wild-type" measles
Kelle Liermann Berggren, Michael Tharp, Kenneth M Boyer
International Journal of Dermatology
|
August 23, 2008
Clinicopathologic challenge. Gangrenous cellulitis caused by Peptostreptococcus
Tracy Campbell, Rachel Altman, Michael Tharp, et al.
American Journal of Clinical Dermatology
|
August 12, 2006
Single-day therapy for recurrent genital herpes
Stephen Tyring, Tim Berger, Angela Yen-Moore, et al.
International Journal of Dermatology
|
March 15, 2006
Prodromal bullous pemphigoid
Philina M Lamb, Edward Abell, Michael Tharp, et al.
Journal of the American Academy of Dermatology
|
February 10, 2024
Efficacy and safety of crisaborole ointment, 2%, in participants aged ≥45 years with stasis dermatitis: Results from a fully decentralized, randomized, proof-of-concept phase 2a study
Jonathan I Silverberg, Robert S Kirsner, David J Margolis, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
May 18, 2011
Multicenter photopheresis intervention trial in early-stage mycosis fungoides
Rakhshandra Talpur, Marie Francis Demierre, Larisa Geskin, et al.
Page
of 1